For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin
Links shared publicly online about this topic.
- 667total visits
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin
View full resource at medicalnewstoday.com
Tags: Cancer, Ovarian Cancer, Healthcare, Pharma, Women's Health
Most Recently Shared on December 9, 2010 at 9:27 pm By:
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carbopl... http://mnt.to/f/3NNW
Also Shared By:
PLD/carboplatin to replace paclitaxel/carboplatin as gold-standard treatment for platinum-sensitive ovarian cancer
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.” View full resource at news-medical.net
Most Recently Shared on December 10, 2010 at 3:43 pm By:
Ovarian Cancer News: PLD/carboplatin to replace paclitaxel/carboplatin as gold-standard treatment for platinum-s... http://bit.ly/gI3hGR
Advertisement
medical_tweets
@medical_tweets
For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin De.. http://dld.bz/AcP7
1 year ago...